Selpercatinib efficacy and safety in patients with RET-altered thyroid cancer: A clinical trial update Meeting Abstract
| Authors: | Sherman, E.; Wirth, L.; Shah, M.; Cabanillas, M.; Robinson, B.; Italiano, A.; Laskin, J.; Subbiah, V.; Drilon, A.; Wright, J.; French, P.; Soldatenkova, V.; Kroiss, M.; Weiler, D. |
| Abstract Title: | Selpercatinib efficacy and safety in patients with RET-altered thyroid cancer: A clinical trial update |
| Meeting Title: | 2022 Deutscher Krebskongress. Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 45 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2022 Nov 13-16 |
| Meeting Location: | Berlin, Germany |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2022-11-01 |
| Start Page: | 55 |
| End Page: | 56 |
| Language: | English |
| ACCESSION: | WOS:000883051700122 |
| PROVIDER: | wos |
| DOI: | 10.1159/000521004 |
| Notes: | Meeting Abstract: 277 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
